Literature DB >> 8890212

Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts.

N Müller1, J M Mansfield, T Seebeck.   

Abstract

The variant surface glycoproteins (VSGs) of African trypanosomes form a dense surface coat on the bloodstream parasites. VSGs are immunodominant antigens that stimulate a rapid antibody response in trypanosome-infected individuals. In the present study, we examined VSG-specific antibodies present not only in sera from infected individuals but also in sera from individuals that had never been exposed to trypanosomes. Native antibodies against different VSGs were detected in sera from uninfected mice, bovines, and humans; the antibodies were revealed to be exclusively directed against variable determinants of the antigens. Further experimentation demonstrated that such native antibodies immunoreact with cellular components of mice and thus are most likely produced by the self-reactive B-cell compartment of the murine immune system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890212      PMCID: PMC174418          DOI: 10.1128/iai.64.11.4593-4597.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

2.  The effects of genetic exchange on variable antigen expression in Trypanosoma brucei.

Authors:  C M Turner; N Aslam; E Smith; N Buchanan; A Tait
Journal:  Parasitology       Date:  1991-12       Impact factor: 3.234

Review 3.  Genetics of antigenic variation in African trypanosomes.

Authors:  E Pays
Journal:  Res Microbiol       Date:  1991 Jul-Aug       Impact factor: 3.992

4.  Active late-appearing variable surface antigen genes in Trypanosoma equiperdum are constructed entirely from pseudogenes.

Authors:  C Roth; F Bringaud; R E Layden; T Baltz; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 5.  Stress proteins, infection, and immune surveillance.

Authors:  R A Young; T J Elliott
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Autoimmunity in experimental Trypanosoma congolense infections of rabbits.

Authors:  J M Mansfield; J P Kreier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice.

Authors:  I Förster; K Rajewsky
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

10.  Two variant surface glycoproteins of Trypanosoma brucei of different sequence classes have similar 6 A resolution X-ray structures.

Authors:  P Metcalf; M Blum; D Freymann; M Turner; D C Wiley
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

View more
  9 in total

1.  Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.

Authors:  M Radwanska; S Magez; A Michel; B Stijlemans; M Geuskens; E Pays
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein.

Authors:  L R Schopf; H Filutowicz; X J Bi; J M Mansfield
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Authors:  Birgitte Giersing; Kazutoyo Miura; Richard Shimp; Jin Wang; Hong Zhou; Andrew Orcutt; Anthony Stowers; Allan Saul; Louis H Miller; Carole Long; Sanjay Singh
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

Authors:  S Magez; B Stijlemans; G Caljon; H-P Eugster; P De Baetselier
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.

Authors:  Tajie H Harris; John M Mansfield; Donna M Paulnock
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

Review 6.  The molecular arms race between African trypanosomes and humans.

Authors:  Etienne Pays; Benoit Vanhollebeke; Pierrick Uzureau; Laurence Lecordier; David Pérez-Morga
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

7.  Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.

Authors:  Liesbeth Van Nieuwenhove; Philippe Büscher; Fatima Balharbi; Michael Humbert; Tessa Dieltjens; Yves Guisez; Veerle Lejon
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

8.  Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle.

Authors:  Enock Matovu; Annah Kitibwa; Albert Picado; Sylvain Biéler; Paul R Bessell; Joseph Mathu Ndung'u
Journal:  Parasit Vectors       Date:  2017-11-03       Impact factor: 3.876

9.  Autoimmunity to phosphatidylserine and anemia in African Trypanosome infections.

Authors:  Juan Rivera-Correa; Joseph Verdi; Julian Sherman; Jeremy M Sternberg; Jayne Raper; Ana Rodriguez
Journal:  PLoS Negl Trop Dis       Date:  2021-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.